Hohl Benjamin plan to sell securities of Enliven Therapeutics, Inc. under Form 144

Hohl Benjamin filed Form 144 to notify SEC of plan to sell 18054 units of Enliven Therapeutics, Inc. securities around 2026-06-17, with aggregate market value of $768,197.70. The total outstanding units is 60900000.0. The amount planned to be sold represents 0.03% of total outstanding units;